BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36249085)

  • 1. Mucormycosis in pre-COVID-19 and COVID-19 era: A study of prevalence, risk factors and clinical features.
    Arjmand P; Bahrami M; Mohammadie ZE; Taherynejad M; Khorasani NY; Mehrad-Majd H; Roshanzamir I; Bakhshaee M
    Laryngoscope Investig Otolaryngol; 2022 Sep; 7(5):1343-50. PubMed ID: 36249085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucormycosis, past and present: a comprehensive review.
    Gupta I; Baranwal P; Singh G; Gupta V
    Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
    Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
    Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Mucormycosis: A Black Fungus Disaster?
    Chillana S; Mohit Chilana KA
    Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Observational Study of Fungal Infections in COVID-19: Highlighting the Role of Mucormycosis in Tertiary Healthcare Settings.
    Singh R; Mittal G; Kakati B; Koul N
    Cureus; 2024 Mar; 16(3):e57295. PubMed ID: 38690487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
    Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucormycosis, New Causative Agents, and New Susceptible Populations: Review of Cases in a Tertiary Care Hospital in Iran (2007-2021).
    Darazam IA; Babamahmoodi A; Ebrahimi MJ; Moafi M; Dilmaghani NA; Mardani M; Shokouhi S; Gharehbagh FJ; Chalmiani EM; Shabani M; Bidari F; Jamali E; Khoshsirat S; Shahriari M; Sabeti S; Rahmani Z; Mousavinejad SA; Ebrahimzadeh K; Hallajnejad M
    Iran J Public Health; 2023 Nov; 52(11):2467-2473. PubMed ID: 38106820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
    Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
    Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
    Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
    Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing trend of fungal infection in invasive rhinosinusitis in the COVID era.
    Garg P; Ranjan V; Avnisha ; Hembrom S; Goel S; Malhotra S
    J Family Med Prim Care; 2024 Apr; 13(4):1428-1433. PubMed ID: 38827671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Observational Study on the Comparison of Different Diagnostic Modalities of Post-COVID Mucormycosis.
    Rani Singh G; Azad S; Kumari M; Kumari S; Kumar S; Ahmed A
    Cureus; 2023 Nov; 15(11):e48925. PubMed ID: 38106762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinocerebral Mucormycosis: An Emerging Threat in the Era of COVID-19.
    Maassarani D; Bassil GF; Nehme M; Nassar A; Ghanime G; Sleiman Z
    Cureus; 2022 Aug; 14(8):e28057. PubMed ID: 36127989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series.
    Singh Y; Ganesh V; Kumar S; Patel N; Aggarwala R; Soni KD; Trikha A
    Cureus; 2021 Jul; 13(7):e16152. PubMed ID: 34354889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
    Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
    Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.
    Muraleedharan M; Panda NK; Angrish P; Arora K; Patro SK; Bansal S; Chakrabarti A; Rudramurthy SM; Bakshi J; Mohindra S; Gupta R; Virk RS; Verma RK; Ramavat AS; Nayak G
    Mycoses; 2022 May; 65(5):567-576. PubMed ID: 35289000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on the Mucormycosis Outbreak: A Deadly Fungal Infection That Followed the COVID-19 Pandemic.
    Patel SN; Shah S; Panchal J; Desai C; Upadhya IB; Patel M
    Cureus; 2023 Feb; 15(2):e35095. PubMed ID: 36938207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
    Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study.
    Sistanizad M; Haji Aghajani M; Haghighi M; Amini H; Pourhoseingholi A; Taherpour N; Ziaie S; Salarian S; Moradi O
    Arch Acad Emerg Med; 2022; 10(1):e56. PubMed ID: 36033988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
    Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
    Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.